Release Date: 02/09/16 15:27 Summary: Valentia Investment Update-EVM.AX Price Sensitive: No Download Document 129.44KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%